Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-solid Organ Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Not applicableUnknownNCT04799808
What this trial is testing

Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff

Who this might be right for
SARS-CoV-2 InfectionActive ImmunizationImmune Response+1 more
Technische Universität Dresden 3,500
Very early researchStudy completedNCT03131934
What this trial is testing

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

Who this might be right for
Post-transplant Lymphoproliferative DiseaseTransplant-Related Hematologic Malignancy
University College, London 4
Not applicableLooking for participantsNCT06341543
What this trial is testing

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Who this might be right for
Cytomegalovirus InfectionsHeart TransplantationKidney Transplantation+2 more
University Hospital, Grenoble 288
Not applicableStudy completedNCT07621835
What this trial is testing

Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in Low-risk CMV-seropositive Kidney Transplant Recipients

Who this might be right for
CMV Specific Immune ResponseKidney TransplantKidney Transplant Recipient+1 more
Maimónides Biomedical Research Institute of Córdoba 236
Testing effectiveness (Phase 2)Study completedNCT00204789
What this trial is testing

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

Who this might be right for
Post-solid Organ TransplantSkin Neoplasms
University of Wisconsin, Madison 52
Early research (Phase 1)Study completedNCT00058604
What this trial is testing

Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).

Who this might be right for
Epstein-Barr Virus InfectionsLymphoproliferative Disorders
Baylor College of Medicine 12